Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Animal Diseases (1)
- Animal Experimentation and Research (1)
- Biology (1)
- Immunology and Infectious Disease (1)
-
- Integrative Biology (1)
- Life Sciences (1)
- Macromolecular Substances (1)
- Medicinal Chemistry and Pharmaceutics (1)
- Microbiology (1)
- Nanomedicine (1)
- Nanotechnology (1)
- Other Immunology and Infectious Disease (1)
- Pharmaceutical Preparations (1)
- Pharmacology (1)
- Pharmacology, Toxicology and Environmental Health (1)
- Research Methods in Life Sciences (1)
- Therapeutics (1)
- Virology (1)
- Virus Diseases (1)
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Macromolecular Prodrug For The Treatment Of Ulcerative Colitis, Yuanyuan Sun
Macromolecular Prodrug For The Treatment Of Ulcerative Colitis, Yuanyuan Sun
Theses & Dissertations
Ulcerative colitis is a chronic inflammatory bowel disease affecting the colon. More than 1 million Americans are affected, with the annual economic burden up to 14.9 billion in the United States. By far, ulcerative colitis still lacks the cure and the current treatment strategies are limited due to severe side effects and in-sufficient efficacy. The tofacitinib (Xeljanz) is the only approved oral medication by for adults with moderately-to-severely-active ulcerative colitis. But the related side effects and serious infections still have to be resolved. In the previous study in our lab, the researchers have successfully developed and characterized multiple hy-drophilic prodrug …
Development Of A Long-Acting Nanoformulation Of Dolutegravir For Prevention And Treatment Of Hiv-1 Infection, Brady Sillman
Development Of A Long-Acting Nanoformulation Of Dolutegravir For Prevention And Treatment Of Hiv-1 Infection, Brady Sillman
Theses & Dissertations
Dolutegravir (DTG) is a potent human immunodeficiency virus type 1 (HIV-1) integrase strand-transfer inhibitor (INSTI) with a high barrier to viral drug resistance. However, opportunities to improve its profile abound. These include extending the drug’s apparent half-life, increasing penetrance to “putative” viral reservoirs, and reducing inherent toxicities. These highlight, in part, the need for long-acting, slow effective release antiretroviral therapy (LASER ART) delivery schemes. A long-acting (LA) DTG was made by synthesizing a hydrophobic and lipophilic prodrug encased with poloxamer (P407) surfactant. This modified DTG (MDTG) reduced systemic metabolism and polarity, increased lipophilicity and membrane permeability, improved encapsulation, and formed …